LAS VEGAS--(BUSINESS WIRE)--Medican Enterprises, Inc. (OTCBB:MDCN), a bio-pharmaceutical company focused on developing and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market, announces it has entered into an amendment agreement on April 29, 2014 which amends the terms to the Subscription Agreement that sets forth the terms of its initial acquisition of 50% of International Herbs Medical Marijuana (IHMML).
Help employers find you! Check out all the jobs and post your resume.
